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Decision Making in the Treatment of Early Colorectal Cancer: A review of 
the literature. 
 
Introduction: 
Colorectal cancer is the second most common cause of cancer death in the United Kingdom 
(Cancer Research UK, 2014). Depending on the location within the large bowel or rectum and 
extent of the disease, options for treatment vary. A National Bowel Cancer Screening Programme 
(BCSP) was introduced into England in 2006, with an aim to reduce colorectal cancer mortality 
(Hewitson et al, 2008). The program offers faecal occult blood tests (FOBt) every two years to all 
men and women aged 60-74. FOBt is designed to detect traces of blood in stool. Large colonic 
polyps and colorectal cancer can bleed into the bowel lumen, thus causing a positive FOBt prior 
to the lesion becoming symptomatic. Individuals with a positive FOBt result are invited for 
colonoscopy. Colonoscopy enables the detection of cancer and the detection and removal of 
adenomas.  Screening the population for bowel cancer in this way, before the onset of symptoms, 
has led to increased numbers of patients being diagnosed with colorectal cancer at an early stage 
(Logan et al, 2012; Ellul et al, 2010). 
 
The National BCSP has also led to an increase in unexpected polyp cancers (Logan et al, 2012), 
whereby polyps are removed during colonoscopy and found to contain a focus of cancer. If there 
are clear resection margins following histopathological assessment, this leads to a dilemma 
whether further treatment in terms of surgery is necessary (Williams et al, 2013). 
 
Treatments for early stage colorectal cancer and polyp cancers often involve several options which 
are preference sensitive, meaning there is not one correct decision. Many less invasive surgical 
procedures are now available. These are summarised in Table 1. Because of this increase in 
treatment options, patients have increasingly more complex decisions to make to balance 
improvements in quality of life against possible reduction in survival. Making the right decision 
on an individual basis is both an issue of quality, in terms of individual lifestyle factors, and safety, 
in terms of likelihood of disease recurrence from less invasive treatments or mortality and 
morbidity of major surgery. This decision is therefore of great significance. 
 Table 1: Newer treatments for early stage colorectal cancer 
Abbreviation Name Description 
EMR Endoscopic 
Mucosal Resection. 
An endoscopic technique developed for the removal of 
sessile benign and early malignant lesions in the GI 
tract using submucosal lift to act as a cushion and 
removal of the lesion either whole or piecemeal using a 
snare (Hwang et al, 2015). 
ESD Endoscopic 
submucosal 
dissection. 
An endoscopic technique like EMR, but specifically 
used to remove lesions en bloc. With ESD the 
submucosa is dissected under the lesion with a knife 
rather than a snare (Maple et al, 2015). 
TEMS Transanal 
Endoscopic 
Microsurgery. 
An operative technique for local removal of early rectal 
cancers using a dedicated rectoscope Usually 
performed under general anaesthetic, for lesions 
between 4 and 15cm from the anal verge. Able to 
perform full thickness resection of the neoplasm with 
1cm margin (Althumairi et al, 2015). 
TAMIS Transanal 
minimally invasive 
surgery. 
Like TEMS, although uses single incision laparoscopy 
port, through which conventional laparoscopic 
instrumentation can be used. Can be used for early 
rectal cancers anywhere in the rectum up to 15cm from 
anal verge. Able to perform full thickness resection of 
the neoplasm with 1cm margin (Althumairi et al, 2015). 
 
 
Literature surrounding the complex process of decision making within the context of early stage 
colorectal cancer is limited. This is most likely because the increase in diagnosis is relatively 
recent. Similarities can be drawn from other preference sensitive decisions in the treatment for 
colorectal cancer, for example choice of operative procedure for treatment of rectal disease.  
 
The UK Government aims to increase patient involvement in treatment decision making 
(Department of Health, 2012), especially where options are preference sensitive. Shared decision 
making is the term used to describe the process whereby clinicians and patients use best available 
evidence together with information about the individual patients’ values, beliefs and treatment 
goals to make decisions together (Elwyn et al, 2012). Studies have demonstrated patients and 
healthcare professionals frequently place different emphasis and priorities on the endpoints of 
treatment including risks and side effects (Pieterse et al, 2008; Masya et al, 2009), therefore 
establishing patients’ preferences for treatment, considering individual values and goals is 
increasingly significant. The aim of this paper is to review the current literature surrounding patient 
involvement in decision making following a diagnosis of early stage colorectal disease. 
 
Method: 
A literature search was undertaken using the following electronic databases: Allied and 
Complementary Medicine Database (AMED), Medical Literature Analysis and Retrieval System 
Online (MEDLINE), Psychology Information (PsychINFO), Cumulative Index to Nursing and 
Allied Health Literature (CINAHL), Psychology Articles (PschARTICLES) and Psychology and 
Behavioural Sciences Collection. Reference lists of articles identified as meeting the inclusion 
criteria were also searched by hand to identify further articles. A date limit was set to 2007. This 
date was chosen to allow the inclusion of only the most recent studies including those reviewing 
more modern treatment options.  The UK National BCSP was launched in 2006, and it was 
anticipated this would trigger more research into earlier stage disease. The date last searched was 
12th April 2017. Available literature published within the ten-year period from 2007-2017 was 
considered. 
 
The inclusion criteria were: 
• Research which explored patient involvement (from a patient or clinician perspective) in 
treatment decision making following a diagnosis of early colorectal cancer. 
• Research available within the timeframe of 2007-2017. 
• Published in English language. 
The exclusion criteria were: 
• Research which focused on palliative care, oncology, screening or genetic testing. 
• Conference extracts, editorials, letters or opinions. 
 
Where other tumour sites were included within the studies, the article was included, but only data 
on colorectal cancer was reviewed. A total of 12 papers (9 research studies, 3 systematic reviews) 
were included which met the criteria of the review. An overview of the 9 research studies is 
provided in Table 2a, and the systematic reviews in Table 2b.  
 Table 2a: List of research studies reviewed 
Author (year) Study description Study 
Origin 
Summary of results Potential biases identified. 
Beaver et al (2007).  Qualitative exploratory study, using 
in depth interviews. Aim: to explore 
views on patient participation 
indecision making, as described by 
health professionals caring for people 
with colorectal cancer.  
England Choices in relation to surgical 
treatment were viewed as 
limited. Health professionals 
made assumptions about 
patient preferences based on 
characteristics such as age.  
Sample of patients taken from three 
NHS Trusts in the Northwest of 
England, therefore Generalisation may 
not be possible elsewhere. 
Large numbers of nursing staff 
interviewed compared to consultants. 
Shepherd, Tattersall 
and Buttow (2007).  
Quantitative survey of cancer 
clinicians to document views on 
shared decision making and discover 
if their views differed according to 
doctor characteristics. 
Multiple cancer specialities included 
in study.  
Australia Clinicians did not report using 
shared decision making 
routinely in their practice.  
Colorectal surgeons may feel 
patients need more direction 
because of lack of treatment 
options. 
Self-reported nature of questionnaire 
design. No method to review individual 
scenarios. 
Low response rate from questionnaires 
(59%) 
Pieterse, et al (2008).  Mixed methods study. Aim: to assess 
what role clinicians prefer in 
deciding about treatment, and how 
they view patient participation in 
treatment. 
The 
Netherlands. 
Almost all participants 
preferred a shared process of 
decision making. Clinicians 
cannot accurately predict how 
treatment outcomes affect 
individual patients. 
Participants had previously participated 
in a study for rectal cancer, therefore 
selection bias may contribute. 
Beaver et al (2009).  
 
 
 
Quantitative study: an attitude rating 
scale was used to explore colorectal 
cancer patients’ views of 
involvement in decision making. 
England Patients wanted to be informed 
and involved in decision 
making, but did not necessarily 
want to take on the role of 
decision maker. 
Use of cross-sectional study-capturing 
views at one moment in time. Findings 
are limited by response bias. Study 
measured attitudes. Attitudes do not 
necessarily determine behaviour. 
Harrison et al, (2008)  
 
 
Mixed methods study, interviews 
performed to investigate preferences 
for treatment for rectal cancer. 
Australia Patients had strong preferences 
against treatment options 
which frequently differed from 
those of physicians. 
Sole focus was on rectal cancer; 
however, scenarios were used on 
patients recently treated for all colorectal 
cancers. The results of the study may 
have been different if only patients with 
rectal cancer had been recruited.  
Author (Year) Study description Study 
Origin 
Summary of results Potential biases identified. 
Shepherd, Butow and 
Tattersall (2011).  
 
 
 
 
 
 
Qualitative study, investigating 
factors which motivate cancer 
doctors to involve their patients in 
treatment decisions. 
Australia Clinicians expressed differing 
support of patient involvement 
in decision making dependent 
on context, impact and effect 
the involvement may have. 
Participants were recruited from a pool 
of clinicians who had been involved in 
similar studies. These participants may 
have been more supporting of patient 
involvement, and may have avoided 
expressing negative views. 
El Turabi et al 
(2013).  
Quantitative survey study, examining 
a single question from the National 
Cancer Patient Survey, examining 
patient experience of involvement in 
treatment decision making. 
England Younger patients had less 
positive experience of decision 
making. Rectal cancer patients 
had worse experiences 
compared to colorectal cancer 
patients. 
The use of a large-scale survey to 
investigate quality of decision making is 
questioned. Response bias, including 
recall and disease severity would have 
an impact on results. 
Snijders et al (2014).  Quantitative study, aimed to explore 
surgeons’ opinion on pre- op 
information which should be given to 
rectal and sigmoid cancer patients 
and to evaluate what was 
communicated. Surgeons attitudes to 
shared decision making were also 
compared with patient involvement. 
The 
Netherlands. 
Insufficient information is 
given to patients with rectal 
and sigmoid cancer to guide 
them on their preferred 
treatment option. Patients were 
hardly involved in the 
treatment decision. 
Only first outpatient consultations were 
studied, therefore some communication 
with the patient could have been missed. 
Surgeons were aware they were being 
recorded, they may have provided more 
information than usual. 
Hirpara, et al (2016).   
Qualitative study, using semi 
structured interviews. 
Aims: to explore the complexities of 
shared decision making within 
colorectal cancer surgery. 
Canada Patients perceived a lack of 
choice and control in decision 
making. Patients identified 
several facilitators to shared 
decision making, including a 
robust support system, 
including family. 
Restricted sample population of one 
large urban area. Almost half of the 
study population had required treatment 
with radiotherapy, suggesting the 
presence of advanced disease. 
Participants recruited were all under the 
care of one surgical oncologist. 
 
 
 
Table 2b: List of systematic reviews 
Author, (year) Study description Study 
Origin 
Summary of results Potential biases identified. 
Hubbard, Kidd and 
Donaghy (2008)  
Systematic review of the 
literature about patients’ 
preferences for involvement in 
cancer treatment decision 
making. 
Scotland Patients preferences for 
involvement in decisions vary 
considerably. It is not possible to 
predict which patients prefer an 
active role.  
Did not complete a full search of all 
available literature. 
Damm,Vogel and 
Prenzler  (2014).  
Systematic review to identify 
patient’s preferences concerning 
treatment preferences and 
involvement in the decision-
making process. 
Germany Colorectal cancer patients have 
preferences regarding treatment 
options and outcomes, which are 
individual and depend on personal 
factors. 
Studies reviewed are mainly prior to 
2009 (only one study 2011). Lack of 
availability of newer surgical 
techniques would have an impact on 
responses. 
Currie et al (2015) Systematic review aimed to 
assess the use of patient 
preference in colorectal cancer 
treatment. 
England Patients are prepared to trade 
significant reductions in life 
expectancy to avoid certain 
complications of colorectal surgery, 
particularly stoma formation. 
The studies reviewed included 
patients who had their treatment in 
the late 1990s and early 2000s, and 
may be less applicable now with 
newer surgical techniques including 
less invasive options. 
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Overview of themes derived from analysis of the papers: 
To provide a comprehensive review of the findings from the papers reviewed, the following 
discussion of the literature review results will be presented under general themes. These themes 
were derived by the author from the analysis of the papers. The first theme related to the situations 
when it is felt ‘ok’ to share treatment decisions with patients. Other themes which were derived 
from reading the papers could be divided into clinician and patient factors. Clinician factors 
included the barriers of time pressures, and the perceptions of clinicians that patients should or 
should not be involved due to personal or disease specific factors. Patient factors included disease 
culture, decision awareness, information giving and the involvement of family members. These 
themes will now be illustrated. 
 
Results 
 
Can all decisions be shared? 
Involving patients is considered more important and more likely to occur where survival outcomes 
for different treatment options are similar (Shepherd, Tattersall & Butow, 2007; Shepherd, Butow 
& Tattersall, 2011). Patients are understandably more often encouraged to be involved where 
decisions are preference sensitive. These are described as ‘grey’ or where more than one treatment 
option is considered appropriate. These ‘grey’ areas contrast with more ‘black and white’ 
decisions, for example in an emergency or where clear evidence exists for one of the pathways. In 
these situations, it is assumed the patient would want to take the decision giving the best outcome. 
The more impact a treatment option has on a patient’s lifestyle the more important a shared 
decision approach is.  
 
 
Clinician factors: 
Initial review of the studies identified that the opinions of clinicians regarding barriers to involving 
patients in treatment decisions are often neglected. Where clinicians are asked to participate in 
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studies (Beaver et al, 2007; Shepherd, 2007; Pieterse, 2008) the aim was to establish their views 
on involving patients in decisions. Without an understanding of the challenges clinicians may 
encounter during a shared decision making process, success is unlikely. 
 
 
Clinician barriers to sharing decisions: 
Appraisal of the literature uncovered three commonly cited barriers to implementing shared 
decision making by health professionals. Firstly, is the barrier of time pressure (Beaver et al, 2007; 
Beaver et al, 2009; Damm, Vogel and Prenzler, 2014; Snijder et al, 2013). Secondly is a lack of 
perceived applicability of involving patients in decisions due to patient characteristics (such as age 
and ability to understand information); (Beaver, et al, 2007; Beaver et al, 2009), and thirdly, there 
is a lack of perceived applicability due to the clinical situation (such as the stage or situation of the 
cancer) (Shepherd, Tattersall & Butow, 2007; Beaver et al, 2007) leading the clinician to make 
assumptions that patients would not want to be involved in the decision.  
 
Time pressure: 
Time pressure barriers are reported as two-fold. Firstly, from a clinician perspective, lack of time 
within the outpatient clinic consultation to allow adequate discussion (Beaver et al, 2009). 
Secondly, a lack of time to allow patients to decide (Damm, Vogel and Prenzler, 2014). 
Confounding this problem is pressure for clinicians to achieve targets such as adherence to NICE 
guidelines for suspected cancer diagnosis (NICE, 2015). Targets such as these may prevent an 
optimum environment for full patient involvement, with pressure for patients to embark on their 
chosen treatment pathway within a target time, reducing time available for them to deliberate 
within their own environment. Pressure to see patients within target of two weeks from referral 
may also increase numbers of patients for the clinician to see in clinic, and reduce time available 
for consultations. These targets should not prevent patients being given as much time as they 
require to decide on options with such huge consequences. 
 
To alleviate the barrier of limited time identified within some of the studies (Damm, Vogel and 
Prenzler, 2014; Beaver et al, 2009) for patients to consider the information on treatment options, 
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a second consultation with the consultant could be offered. Second consultations could enable 
patients time to discuss options with family/ specialist nurse; although one study by Snijders,et al, 
(2014) identified that a second consultation pre-operatively may not be practical. Certainly, within 
the UK, short timescales to surgery due to adherence to targets (as previously discussed, NICE, 
2015), would be a barrier to this suggestion. Alternatives to a second consultation could be 
considered; for example, giving printed information, videos describing therapeutic options and 
risks and benefits before the first consultation. The availability of such resources, especially for 
diagnoses such as polyp cancers, are at present scarce (Snijders et al, 2014).  
 
Lack of perceived applicability of involving patients in decisions due to patient characteristics: 
Shepherd, Tattersall and Butow, (2007); Shepherd, Butow and Tattersall, (2011) and Harrison et 
al, (2008) all suggest that clinicians appear to value the concept of shared decision making although 
they acknowledge that patients do not always want to be fully involved in the process.  
Whilst the difficulties in distinguishing the desire of patients to be involved in decision making 
have been identified (Beaver et al, 2007; Pieterse et al, 2008; Hubbard et al, 2008), the challenge 
for clinicians is to minimise misunderstandings and misinterpretations of risks and benefits 
involved in the choices available (Harrison et al, 2008; Snijders et al, 2014). The findings of one 
study by Hirpara et al (2016) mirror other studies (Beaver et al, 2007; Pieterse et al, 2008; Hubbard 
et al, 2008), which have been unable to identify specific characteristics for individual patients to 
enable clinicians to predict the level of involvement a patient may prefer. 
 
The ‘active’ decision maker role assumed by some knowledgeable patients can result in frustration 
for health professionals when choices are made in the absence of scientific evidence (Beaver et al, 
2007). There can be disbelief that patients may not always choose options based on prolonging 
their life. This perspective represents a lack of appreciation by health care professionals of the 
importance of quality of life to patients, and how individual opinions differ. Currie et al, (2015) 
highlighted the importance of discussing patient choice in relation to colorectal surgery, 
identifying that patients are prepared to trade significant reductions in life expectancy to avoid 
certain complications, particularly stoma formation. 
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Clinicians perception that younger patients want more information and choice was one of the 
findings reported by Beaver et al, (2007). This perception may hinder the options for the older 
generation to engage in the decision making process. Beaver et al, (2009) report that older patients 
are traditionally used to paternalistic approaches to treatment decisions in healthcare and may 
appear unwilling to enter discussions regarding concerns and priorities for treatment outcomes, 
believing ‘the doctor knows best’. Williams et al, (2013) acknowledge there may be a perception 
that any side effects of treatment are not as important to older patients as they have a shorter life 
expectancy; however, deterioration in health may have an impact on the levels of independence 
and social isolation, therefore it is important that clinician assumptions are avoided.  
 
 
 
 
 
Lack of perceived applicability due to clinical situation. 
 
Earlier studies (Shepherd, Tattersall & Butow, 2007; Beaver et al, 2007), report that health 
professionals felt choices in colorectal cancer treatments were limited with the only options being 
whether to have surgery or not. As discussed previously, both studies relate to treatment options 
for definite bowel cancer, where options for treatments were limited. Since the publication of these 
studies, the National Bowel Cancer Screening Programme has led to diagnosis of disease at an 
early stage, with increased preference sensitive options, and an increase in the necessity to base 
options around patient values and preferences.  
 
Power relationships between clinician and patient may also affect patient involvement in decision 
making. For example, when a surgeon discusses the choice between surgery or no surgery in the 
treatment of a polyp cancer. Shepherd, Butow & Tattersall (2011), report that surgeon bias towards 
surgery may contribute to patient interest in surgery. Research around this topic however, is scarce. 
Recommendations made by Shepherd, Butow & Tattersall (2011), are that the perspectives of 
patients who declined surgery are studied further to understand why they have made this decision.   
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Patient factors: 
El Turabi et al, (2013) explored variation in involvement in decision making as part of the English 
2010 National Cancer Patient Experience Survey, one of the largest ever undertaken. They found 
more positive experiences of involvement are associated with reduced decisional conflict, greater 
satisfaction with treatment decisions and improved patient wellbeing. This could translate into 
further improvements for Trusts such as reduced dissatisfaction with services, complaints and 
litigation.  Results of the survey concur that the younger age group report substantially less positive 
experience, reflecting the expectation of greater involvement as previously discussed. 
 
Trust in health care staff is still identified as a major facilitator in decision making (Hirpara, et al, 
2016), having previously been reported within a survey of colorectal cancer patients’ attitudes in 
decision making (Beaver et al, 2009). One of the aims of the study by Beaver et al, (2009), was to 
explore patient attitudes towards involvement in decision making. The study also included the 
development and piloting of an attitude scale to enable this exploration to be achieved. Results 
from the study showed that most patients wanted to be involved in their treatment decisions 
(94.7%), however this did not necessarily mean they wanted to completely make the decision on 
their own. Most patients (95.5%) reported that trust in the doctor to decide the best treatment for 
them was very important to them, however, they also reported that if the doctor told them 
everything, they were more likely to want to make decisions.  
 
 
Disease culture: 
Disease culture refers to the social and public profile of the disease (Shepherd, Butow & Tattersall, 
2011). The existence of active consumer groups encourages patients to be more educated about 
the disease and to play an active role in treatment decisions. The higher profile in terms of public 
involvement, charities improving disease awareness and options for early diagnosis means patients 
are more likely to want to be involved. Although it appears colorectal cancer may not enjoy the 
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same high profile as other cancer disease groups such as breast, national charities and the national 
BCSP are very active in promoting awareness and may be of benefit to future patients. 
 
 
Decision awareness: 
Hirpara et al, (2016), identified a perceived lack of choice and control by patients. The life-
threatening nature of the initial cancer diagnosis can lead patients to believe surgical intervention 
is inevitable, and there are no decisions to be made. Improving patient awareness of the preference 
sensitive nature of the decision and the nature of all options available is significant. 
Recommendations from a study aiming to explore surgeons’ opinion on the content of pre-
operative information for patients diagnosed with rectal and sigmoid cancers, (Snijders, et al, 
2014), include creating an awareness that different options are available for which there may be 
no best choice. These options may affect the individual in different ways, and choices depend on 
very individual factors. It may be a surprise to patients to learn the reality that outcomes in 
medicine are not certain, and real choices are available (Shepherd, et al, 2007 
 
 
Information giving: 
Information giving is considered a major factor in successfully sharing treatment decisions (Beaver 
et al, 2009; Harrison et al, 2009). The Dutch study by Snijders et al (2014), aimed to explore 
surgeons’ opinions on what pre-operative information should be given to patients undergoing 
rectal and sigmoid cancer surgery, compared to what is communicated in practice. Results showed 
that patients were insufficiently and inconsistently informed of the risks of surgery, and 
information given to them was incomplete. The clinical implications of rectal and sigmoid cancers 
are that surgery to this area of the bowel is more likely to result in the formation of a stoma than 
surgery on other areas of the bowel. Even if surgery to the rectum or sigmoid does not involve a 
stoma, side effects from surgery to this area such as alteration in bowel function are more common 
and could include incontinence (Knowles et al, 2013). The importance of a study such as that 
performed by Snijders et al, (2014) is that the implications for patient quality of life are significant 
in this situation.  
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Involvement of family members: 
Many of the studies surrounding patient involvement in decision making in colorectal cancer focus 
on the patient’s encounter with the clinical team (Beaver et al, 2009; Hubbard, Kidd and Donaghy, 
2008; Damm, Vogel and Prenzler, 2014). A recognition of this fact is made by Hirpara, et al, 
(2016) within a qualitative study aimed at examining complexities of interactions within the 
decision making process not only with patients but also including their families and the health care 
team. Following telephone interviews with twenty patients, a key finding was that of the 
importance of family involvement in the decision making process. Recommendations from the 
study are that health care teams should have a greater awareness of the impact family members 
may have on the process.  An example may be the patient’s concern about how their choice of 
treatment may impact on the dynamics of family life.  
 
Conclusions: 
 
Shared decision making as a concept has been discussed by healthcare professionals for some time. 
It is clear from the literature that we are not reaching the goals of shared decisions. Barriers exist 
preventing clinicians and patients from achieving these. The main barriers being a failure in 
communicating the preference sensitive nature of the decision to patients, together with the 
implications of treatment outcomes. Making assumptions of patients’ beliefs and values must be 
prevented.  
 
Many of the studies within this review related to choices between different types of surgery for 
rectal cancer; for example, low anterior resection and abdominoperineal resection. Whilst this 
topic still illustrates the complexities of decisions made, it does not necessarily represent the newer 
problems presented by minimally invasive techniques for early stage disease such as the 
endoscopic resection of unexpected polyp cancers, or transanal endoscopic microsurgery 
(Nakajima et al, 2013). These treatments offer patients preference sensitive choices with important 
life altering decisions to be made.   
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The treatment decision making process in patients diagnosed with early colorectal cancer or polyp 
cancer is not clearly understood. Reasons for this lack of understanding stem from the absence of 
studies exploring the experiences of clinicians and patients in this area. Presumptions of the issues 
can be made from examining the literature on decision making in similar clinical areas; however, 
the situation of a patient faced with treatment options following a diagnosis of very early colorectal  
cancer is unique and needs to be fully understood. 
 
There is an obvious gap in knowledge of the treatment decision making process around early 
colorectal cancer and polyp cancers. Further studies in this area are required to address this gap, 
specifically incorporating the perspective of clinicians as this is likely to be the most challenging 
barrier to overcome. Beyond this recommendation, further studies are required to establish the 
optimal model for improving the decision-making process in this area.  
 
 
Table 3: Key Findings 
• Patients may not understand that their treatment options are ‘preference sensitive’. 
• Time pressures exist, both in the outpatient clinic setting, and the time between clinic 
appointments to allow patients ‘time to think’. 
• Patient characteristics such as age may prevent clinicians including patients in 
treatment decision making. 
• Clinical situations such as the extent of the disease may prevent clinicians including 
patients in treatment decision making. 
• Trust in the clinician is a big enabler for patients to be involved in decisions. 
• The quality and quantity of information is important to enable a fully informed 
decision maker. 
• Family members play a big part in patients decisions. 
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